zantac lawsuit Updates
Illinois Jury Rules in Favor of Boehringer Ingelheim
An Illinois jury has ruled in favor of Boehringer Ingelheim, rejecting claims that long-term Zantac use contributed to prostate cancer diagnoses. The verdict was reached after just two hours of deliberation in a four-week retrial, following hung juries in previous proceedings. Other Illinois juries have also dismissed similar claims in recent trials. While some Zantac-related cancer claims remain stronger—such as those involving bladder, esophageal, and stomach cancer—this latest defense verdict represents a setback for plaintiffs. Future trials will be critical in determining the strength of remaining claims and whether plaintiffs can build momentum in the litigation.
Zantac Retrial Focuses on Cancer Risk Disputes
In the ongoing Zantac retrial, the defense claims no studies link the drug to prostate cancer, while plaintiffs argue the research cited is based on unrealistic dosing scenarios. Cross-examination revealed that manufacturers did not test for NDMA contamination before 2019, despite knowing the drug degraded over time. The FDA recalled Zantac in 2020, but plaintiffs contend this action was too late. Previous juries have deadlocked in prostate cancer cases, making this retrial a key test for plaintiffs, though these claims face greater challenges compared to other Zantac-related lawsuits.
Testimony Highlights Concerns Over Zantac Degradation
At last week’s Illinois retrial, Boehringer Ingelheim’s corporate representative minimized the discoloration of Zantac pills, describing it as a cosmetic issue rather than a sign of chemical instability. However, her testimony has raised concerns about the company’s failure to investigate the underlying cause. The plaintiffs’ counsel contested the assertion that coating the pills was a benign measure, citing internal discussions about reformulating the drug’s outer layer, which imply awareness of a deeper defect. Additionally, Boehringer’s claim of discontinuing discoloration testing due to “consistency” suggests repeated degradation. The witness also shifted responsibility for ranitidine instability to GlaxoSmithKline and questioned the internal review processes of pre-2019 studies.
Boehringer Ingelheim Zantac Retrial in Illinois
The first Zantac trial of 2025 will take place in Illinois, focusing on two plaintiffs accusing Boehringer Ingelheim of ignoring warnings about the cancer risks of its over-the-counter Zantac. Their lawyers will present evidence showing that ranitidine, Zantac's active ingredient, can break down into NDMA, a harmful substance. This retrial follows previous mistrials for both plaintiffs, with claims related to prostate cancer. While the science is strong, the jury appeal is more limited. However, Cook County juries are typically favorable to plaintiffs, and there is optimism for a significant verdict.
About Zantac Lawsuit
For heartburn sufferers, Zantac seemed a blessing because of its effectiveness. However, in recent years, the once-popular heartburn medication has been linked to serious health risks.
For years, millions of people trusted Zantac to relieve their acid reflux and heartburn.
Unfortunately, recent discoveries have shown that Zantac and other ranitidine products could contain dangerous levels of a cancer-causing chemical called NDMA. Without a doubt, the news is alarming because many people have used Zantac daily for years without ever realizing they were putting their health at risk.
Studies have revealed that NDMA in Zantac has a link to certain types of cancers including stomach, liver, bladder, and pancreas.
Have you or a loved one recently developed a cancer that you believe is related to the long-term use of Zantac? If so, you are not alone and you do have legal options such as joining a class action lawsuit to seek compensation.
Who Can Pre-Qualify In The Zantac Lawsuit?
Have you or a loved one used Zantac? If so, you may be eligible to participate in a Zantac class action lawsuit.
Do you meet the following criteria?
- You took Zantac or another ranitidine product regularly.
- You were diagnosed with cancer linked to NDMA exposure, such as bladder or stomach cancer.
- You can provide medical records showing your diagnosis and Zantac usage.
You may also pre-qualify if you've been diagnosed with the following cancer(s).
- Liver Cancer
- Stomach/Gastric Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Bladder Cancer
- Intestinal (Not Colorectal)
Please note: You must have been diagnosed January 1st, 2000 - current year to pre-qualify. In addition, you must be a non-smoker and have used Zantac for a minimum of one year.
If you meet the above requirements, you may be entitled to compensation. We encourage you to seek legal advice to determine your eligibility. Various factors impact eligibility and all cases are unique.
Participating in a Zantac class action lawsuit could help you obtain monetary compensation to pay for your medical bills, pain, and suffering.
Which Companies Are Involved in the Zantac Lawsuits?
The makers of Zantac, including major pharmaceutical companies, are facing lawsuits. These companies are accused of failing to warn consumers about the risks of NDMA contamination in their products. Even after learning the risks of NDMA, the companies continued to market and sell Zantac even after the potential dangers became widely known.
As more information emerges, it is believed that the number of cases against these companies will grow by leaps and bounds. If you or someone you care about has been impacted by Zantac use, then you may have a case.
What Compensation Can You Expect in a Zantac Lawsuit?
The amount of compensation you might receive depends on a variety of factors, such as:
- The type and severity of your cancer.
- How long have you used Zantac?
- The evidence that links your cancer with Zantac use.
Currently, Zantac lawsuits remain in their infancy and no major settlements have been reached. However, based on similar cases, compensation could be significant, especially for those who have suffered the most.
Has your health been impacted by Zantac use? If yes, do not wait. Reach out today to learn if you may pre-qualify to participate in a Zantac lawsuit.
Add Comment